Incorporating MRI and biomarkers in active surveillance protocols – results from the prospective Stockholm3 Active Surveillance trial (STHLM3AS).

Active surveillance (AS) for men with low-risk prostate cancer (PC) can lead to patient morbidity and healthcare overutilization. The aim of this study was to evaluate an AS-protocol using the Stockholm3 test and MRI to reduce biopsy intensity.